Biopure Presentation 3

Biopure Presentation 3 - Biopure Corporation Team 1: Rusty...

Info iconThis preview shows pages 1–7. Sign up to view the full content.

View Full Document Right Arrow Icon
OEM Team 1 1 Biopure Corporation Team 1: Rusty McLaughlin Larry Miller Corrie Musgrave Luke Setzer
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Hemopure Market Potential US Markets (* Price is $500-1000 per unit) Use of red blood cells (million units) Market Size* (billion dollars) Potential % Potential Market (billion dollars) Acute Blood Loss Elective Surgery Anonymous Donated 5.8 $2.9-5.8 50% $1.45-2.9 Autologous Donated 1.1 $.55-1.1 50% $.275-.55 Emergency Surgery (hospital) 1 $.5-1 50% $.25-.5 Trauma (in field administration) 0.2 $.1-.2 50% $.05-.1 Chronic Anemia 3.2 $1.6-3.2 50% $.8-1.6 Not Transfused Due to Rejection 1.2 $.6-1.2 50% $.3-.6 Due to Expiration 1.5 $.75-1.5 50% $.375-.75 Borderline ~ 1.5 $.75-1.5 50% $.375-.75 Total
Background image of page 2
OEM Team 1 3 Hemopure Market Target Market Trauma (in field administration) 100,000 units annually Emergency surgery 500,000 units Max capacity 150,000 units annually Elective Surgery (anonymously donated ) Chronic Anemia Elective Surgery (Autologously donated ) Emergency Surgery 0.5 Million Units 0.55 Million Units 1.6 Million Units 2.9 Million Units Trauma (Field Admin.) 0.1 Million Units Borderline Surgery (< 2 units) 0.75 Million Units Additional Unknown Demand Estimated at 1.35 Million Units from discarded donated units
Background image of page 3

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
OEM Team 1 4 Hemopure Market Who benefits? Trauma and emergency surgeries “must have – life blood” increase patient survival rate Elective (anonymous donation) and Borderline cases represent near future expansion Chronic anemia patients, won’t benefit from weak persistence; frequency of transfusions increase Elective (autologous donation) unlikely to switch; prefer own blood to animal-based blood Some demand undefined by given data Who typifies market? Senior citizens comprise 40% of US transfusions (1995) Segment expected to increase over subsequent 35 years
Background image of page 4
OEM Team 1 5 Market Factors Market Trends Summary Factors affecting market size How this affects customer base Rationale and supporting data Demographics Demographic trends indicate that the population is growing The population is aging 1995 Census Data Economy Economic trends indicate that the population is stable The economy is stable Funding Funding trends indicate that the population is stable Health Insurance companies likely to fund program Political Climate Political Climate trends indicate that the population is stable Policies promoted by politicians are unlikely to make the FDA approval process more strict Overall impact of trends on need or demand Based on all the trends above, the population is growing The population is aging and trauma cases are on the rise Overall impact of trends on availability of funds Based on all the trends above, the health insurance programs will pay for product because need is on rise. Economy is stable, increased projected need, and health insurance programs have mutual benefit. Duration of trends The impact of these trends is expected to be long in duration Projections on population extend ~ 35 years
Background image of page 5

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
OEM Team 1 6 Human Market Implications Human market has high profit potential, high risk Costly FDA approval process Multi-phased; ranges in complexity, and can last 10-20 years US requirements for humans assumed to be more restrictive than for animals Oxyglobin has been approved
Background image of page 6
Image of page 7
This is the end of the preview. Sign up to access the rest of the document.

Page1 / 25

Biopure Presentation 3 - Biopure Corporation Team 1: Rusty...

This preview shows document pages 1 - 7. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online